Today, Bioxyne found itself in the national spotlight. An ABC news segment featured the company's pharmaceutical manufacturing operations, including medicinal...

From Melbourne Cannabis Startup to NASDAQ Biotech Contender When historians eventually document Australia's contribution to the modern psychedelic medicine movement,...

The psychedelic medicine movement has crossed a threshold. What was once relegated to the fringes of science, dismissed by policymakers,...

When historians eventually document the modern psychedelic renaissance in Australia, they will likely focus on a handful of landmark moments....

For more than half a century, psychiatry has focused primarily on the brain. Depression, anxiety, post-traumatic stress disorder, and other...

Beyond SSRIs lies a global battle between pharma, therapy, technology, and the future of human consciousness. For decades, modern psychiatry...

How a tiny Perth microcap quietly ended up inside one of the world’s most important psychiatric experiments At first glance,...

There was a time when psychedelic conferences were niche gatherings held on the fringes of medicine. Researchers spoke cautiously. Therapists...

A few years ago, psychedelic stocks looked unstoppable. Retail investors piled into newly listed biotech companies promising to revolutionise mental...

How Australia’s tightly controlled psychedelic medicine framework is now influencing global conversations around mental healthcare, regulation, and biotech investment Australia...